Candel Therapeutics, Inc. Common Stock (CADL)
Candel Therapeutics, Inc. Common Stock
XNAS:CADL
5.57
$5.58 - 200.00
$5.56 - 1,217.00
$5.4
$5.65
$5.42
$5.33
14.6
4.25
591092
841734
41058713.06
Chart
TendieTensor AI Analysis
Company
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Fundamentals
38
-9.530000
3.651790
-0.21
100
BBG00N0D4Z71
BBG00N0D4Z80
54.90M
54.90M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CADL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.